ELOX · Eloxx Pharmaceuticals, Inc.
$12.79
+0.55 (+4.45%)
At close · Jul 30
Going-concern doubt
— flagged May 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our recurring losses from operations raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed May 5, 2026
Market Cap
$98.61M
Shares
7.57M
Eloxx Pharmaceuticals, Inc. Earnings Call Transcripts
Every quarterly earnings call for Eloxx Pharmaceuticals, Inc. (ELOX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY21 · Q3
2021-11-09
Eloxx Pharmaceuticals, Inc. Q3 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
Eloxx Pharmaceuticals, Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Eloxx Pharmaceuticals, Inc. Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Eloxx Pharmaceuticals, Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Eloxx Pharmaceuticals, Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Eloxx Pharmaceuticals, Inc. Q4 FY2019 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–6 of 6 earnings calls